Join us in October for our exclusive ramarketing roundtables…

24th September, 2020

2020’s CPhI event may be cancelled, but we are marking the occasion with our own exclusive event!

Raman Seghal (founder) and Laura Child (CRO Sector Lead) are facilitating a series of 60 minute roundtable discussions together with our clients, over the course of four days in October – Thursday 8th, Friday 9th, Monday 12th and Tuesday 13th.

The sessions are completely free to attend via Zoom and are purely to share knowledge and add value for our audience. You can sign up to attend here (we’ll then be in touch with access details), or scroll a little further for more details about our guests and discussion topics…

Listen to the episodes

We may be missing out on the face to face element of CPhI itself but there is so much happening in the industry and these conversations are absolutely invaluable to hear key developments, plans, news and insights both now and into the coming year. We want to make sure that the vital conversations that would usually take place at CPhI, still have a platform to take place – albeit in virtual format!

We are super excited for this and we cannot wait to share discussions around the latest news, plans and trends. Hope to see you there!

Event agenda

Thursday 8th October (3-4pm BST, 10-11am ET) – Global geography and the pharma and bio supply chain.

We’ll discuss the impact of COVID-19 and increasing concerns around safety and environmental impact relating to materials suppliers. We’ve seen recurring trends involving companies in the industry altering strategy to ensure they have second and third supplier options. We’ll explore this adaptation and further changes triggered by the pandemic.


  • Raman Sehgal, Founder & Global President at ramarketing
  • Lara Child, CRO Sector Lead at ramarketing
  • Erik Haeffler, VP Manufacturing Services & Head of Sustainability at Recipharm AB

Friday 9th October (3-4pm BST, 10-11am ET) – Clinical trials in 2020 and beyond.

We’ll explore the impact of COVID-19 on traditional clinical trial processes to highlight how the industry has adapted. We will cover topics including ‘direct to patient treatment’ and trends that highlight a move away from the ‘norm’ in order to survive and thrive.


Monday 12th October (3-4pm BST, 10-11am ET) – Latest trends in CDMO.

This session will involve a wider discussion around COVID-19 related trends and also natural progression in the CDMO space. We will begin by exploring recurring trends involving futureproofing and digitisation across the industry including a growing need for automation.


  • Raman Sehgal, Founder & Global President at ramarketing
  • Lara Child, CRO Sector Lead at ramarketing
  • Roger Lias, Chief Executive Officer at Stelis Biopharma Pvt. Ltd. and Stelis Biopharma LLC
  • Mark Quick, Executive Vice President Corporate Development at Recipharm AB

Tuesday 13th October (3-4pm BST, 10-11am ET) – Collaboration and driving efficiency.

During this discussion we will explore two angles to driving efficiency, diversification vs. development of specialism. Emerging trends include the move to manufacture multiple technologies under one roof, at the other end of the scale we see companies staying true to original areas of expertise in order to refine and grow.


Hope to see you there!